These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29291456)

  • 21. [Early infantile epileptic encephalopathy type 14: three cases of epilepsy in infancy with migrating focal seizures due to KCNT1 mutations].
    Kholin AA; Zavadenko NN; Fedonyuk ID; Antonets AV; Mukhin KY; Malov AG; Vshivkov MI; Anisimov GV; Il'ina ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7. Vyp. 2):74-82. PubMed ID: 31532594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.
    Rizzo F; Ambrosino P; Guacci A; Chetta M; Marchese G; Rocco T; Soldovieri MV; Manocchio L; Mosca I; Casara G; Vecchi M; Taglialatela M; Coppola G; Weisz A
    Mol Cell Neurosci; 2016 Apr; 72():54-63. PubMed ID: 26784557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intolerance to quinidine in a n-of-1 trial for KCNT1 associated epilepsy of infancy with migrating focal seizures.
    Hughes E; Oates S; Pal DK
    Seizure; 2022 Dec; 103():46-50. PubMed ID: 36279596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
    Poisson K; Wong M; Lee C; Cilio MR
    Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision therapy with quinidine of KCNT1-related epileptic disorders: A systematic review.
    Xu D; Chen S; Yang J; Wang X; Fang Z; Li M
    Br J Clin Pharmacol; 2022 Dec; 88(12):5096-5112. PubMed ID: 35940594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects.
    Lim CX; Ricos MG; Dibbens LM; Heron SE
    J Med Genet; 2016 Apr; 53(4):217-25. PubMed ID: 26740507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
    Milligan CJ; Li M; Gazina EV; Heron SE; Nair U; Trager C; Reid CA; Venkat A; Younkin DP; Dlugos DJ; Petrovski S; Goldstein DB; Dibbens LM; Scheffer IE; Berkovic SF; Petrou S
    Ann Neurol; 2014 Apr; 75(4):581-90. PubMed ID: 24591078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.
    Barcia G; Chemaly N; Kuchenbuch M; Eisermann M; Gobin-Limballe S; Ciorna V; Macaya A; Lambert L; Dubois F; Doummar D; Billette de Villemeur T; Villeneuve N; Barthez MA; Nava C; Boddaert N; Kaminska A; Bahi-Buisson N; Milh M; Auvin S; Bonnefont JP; Nabbout R
    Neurol Genet; 2019 Dec; 5(6):e363. PubMed ID: 31872048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2
    Passey CC; Erramouspe J; Castellanos P; O'Donnell EC; Denton DM
    Curr Ther Res Clin Exp; 2019; 90():106-108. PubMed ID: 31388363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.
    Kravetz MC; Viola MS; Prenz J; Curi M; Bramuglia GF; Tenembaum S
    Front Pharmacol; 2021; 12():648519. PubMed ID: 34122071
    [No Abstract]   [Full Text] [Related]  

  • 31. Two South Indian Children with KCNT1-Related Malignant Migrating Focal Seizures of Infancy - Clinical Characteristics and Outcome of Targeted Treatment with Quinidine.
    Patil AA; Vinayan KP; Roy AG
    Ann Indian Acad Neurol; 2019; 22(3):311-315. PubMed ID: 31359944
    [No Abstract]   [Full Text] [Related]  

  • 32. Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.
    Miziak B; Czuczwar SJ
    Expert Opin Drug Discov; 2022 Dec; 17(12):1313-1328. PubMed ID: 36408599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
    Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coupling of Slack and Na
    Yuan T; Wang Y; Jin Y; Yang H; Xu S; Zhang H; Chen Q; Li N; Ma X; Song H; Peng C; Geng Z; Dong J; Duan G; Sun Q; Yang Y; Yang F; Huang Z
    Elife; 2024 Jan; 12():. PubMed ID: 38289338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population.
    Qu J; Zhang Y; Yang ZQ; Mao XY; Zhou BT; Yin JY; He H; Li XP; Long HY; Lv N; Xu XJ; Xiao B; Zhang Y; Tang Q; Hu DL; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2014 Feb; 20(2):140-6. PubMed ID: 24279416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinidine Therapy for Lennox-Gastaut Syndrome With
    Jia Y; Lin Y; Li J; Li M; Zhang Y; Hou Y; Liu A; Zhang L; Li L; Xiang P; Ye J; Huang Z; Wang Y
    Front Neurol; 2019; 10():64. PubMed ID: 30804880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinidine-associated skin discoloration in
    Baumer FM; Sheehan M
    Neurology; 2017 Nov; 89(21):2212. PubMed ID: 29158296
    [No Abstract]   [Full Text] [Related]  

  • 38. Three Cases of KCNT1 Mutations: Malignant Migrating Partial Seizures in Infancy with Massive Systemic to Pulmonary Collateral Arteries.
    Kawasaki Y; Kuki I; Ehara E; Murakami Y; Okazaki S; Kawawaki H; Hara M; Watanabe Y; Kishimoto S; Suda K; Saitsu H; Matsumoto N
    J Pediatr; 2017 Dec; 191():270-274. PubMed ID: 28987752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of ketogenic diet in a girl with migrating partial seizures in infancy.
    Mori T; Imai K; Oboshi T; Fujiwara Y; Takeshita S; Saitsu H; Matsumoto N; Takahashi Y; Inoue Y
    Brain Dev; 2016 Jun; 38(6):601-4. PubMed ID: 26785903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
    M Qunies A; A Emmitte K
    Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.